Kiniksa Pharmaceuticals International, plc Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Kiniksa Pharmaceuticals International, plc (KNSA) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $250.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Notes
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2021-11-04
- 2021-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $250.00K.
- 2021-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $500.00K.
- 2021-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $750.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2021-09-30 | $250.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $500.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $750.00K 10-Q · filed 2021-05-06 |